Vivacitas Oncology to Present AR-67 at the Biotech Showcase Investor Conference
Jan 10, 2022
Vivacitas Oncology, Inc. ("Vivacitas" or the "Company"), a privately held clinical stage biopharmaceutical company focused on tough-to-treat cancers, today announced it will present at the 2022 Biotech Showcase™ conference with an online presentation.
Mark Suseck, Vivacitas CEO & Director, will present an overview of the company, its lead compound (AR-67), and clinical development plans. Mr. Suseck stated, "We look forward to participating in this year's Showcase and sharing an update on our efforts to deliver potential new treatment options for oncology patients."
Biotech Showcase™ is an investor and networking conference focused on innovative private and micro-mid-cap biotechnology companies.
Presentation details can be found below:
| Title | Vivacitas Oncology Inc. |
| Presenter | Mark Suseck |
| Date | Tuesday, Jan. 11, 2022 |
| Time | 3:15 PM (PST) / 6:15 PM (EST) |
For registration, click here.
ABOUT VIVACITAS ONCOLOGY:
Vivacitas Oncology is a private clinical-stage biopharmaceutical company focused on tough-to-treat cancers. It originated with the vision of Dr. Joseph Rubinfeld (co-founder of Amgen) and Infusion 51a, LP to transform select chemotherapies beyond their initial potency, toxicity, stability, and/or pharmacokinetics challenges and unlock maximum treatment and tolerability potential. Through an enduring spirit, Vivacitas continues to apply clarity, tenacity, and vision in our fight against aggressive cancers and our pursuit of new treatment options for patients and their families worldwide.
For further information please visit www.vivaoncology.com or [email protected]
Press Release Service by Newswire.com
Original Source: Vivacitas Oncology to Present AR-67 at the Biotech Showcase Investor Conference
More News
In Anthropic I.P.O., Goldman and Morgan Stanley Slug It Out for Top Bank
Anthropic named the Wall Street firms lead underwriters on its upcoming public offering, a role that will generate generous fees and enormous prestige.
Apple to replace iPhone Duos affected by screen problem
Photos shared online showed faults appearing on the screens of Apple's first foldable device.
In Anthropic I.P.O., Goldman and Morgan Stanley Slug It Out for Top Bank
Anthropic named the Wall Street firms lead underwriters on its upcoming public offering, a role that will generate generous fees and enormous prestige.
The Fed Is Expected to Hold Rates Steady. Warsh Will Have to Explain Why.
Inflation is moving in the wrong direction and the labor market remains stable, a combination that bolsters the case for higher interest rates.
Why Is Halloween Candy So Expensive?
The average cost of a 100-piece bag has jumped 71 percent in the last five years. Consumers are thinking twice about what they’ll spend.
In the A.I. ‘Robogym,’ Machines Train to Be More Like Humans
Germany’s Neura is one of the companies at the forefront of efforts to use artificial intelligence in robotics, and crucial to whether Europe can close the gap with China.
Rise in sales of radios and tinned foods, say retailers, after call to stock up
Figures obtained by BBC Newsnight show large spikes in sales of torches, radios and power banks.
Will the Budget pass Burnham's Makerfield test?
People in the prime minister's constituency say rising costs are squeezing household finances.
First-time buyers hoping for help from the Budget
Aspiring homeowners say rent, rising costs and house prices are delaying plans to buy.
Budget 2026: 'Surrey is a lovely place - but it can be stressful'
Ahead of the Budget, residents tell BBC Radio Surrey their experiences of the cost-of living crisis.
Donald Trump's biggest economic problem looks strangely familiar
Donald Trump heads into the US midterm elections with an issue similar to his political foe Joe Biden.
Business Daily
After decades of ultra-cheap money, the cost of borrowing in Japan is rising
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.